Quantinno Capital Management’s AbbVie ABBV Stock Holding History

Quantinno Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$287M	Buy	1,138,736 +186,646	+20%	+$40.2M	0.34%	30
2026 Q1	$207M	Buy	952,090 +182,393	+24%	+$40.5M	0.35%	28
2025 Q4	$176M	Buy	769,697 +161,579	+27%	+$36.8M	0.35%	26
2025 Q3	$141M	Buy	608,118 +215,427	+55%	+$43.9M	0.38%	29
2025 Q2	$72.9M	Buy	392,691 +86,440	+28%	+$16.1M	0.31%	33
2025 Q1	$64.2M	Buy	306,251 +116,820	+62%	+$22.7M	0.42%	28
2024 Q4	$33.7M	Buy	189,431 +31,871	+20%	+$5.86M	0.33%	36
2024 Q3	$31.1M	Buy	157,560 +54,769	+53%	+$10.2M	0.4%	31
2024 Q2	$17.6M	Buy	102,791 +767	+0.8%	+$127K	0.32%	41
2024 Q1	$18.6M	Buy	102,024 +35,789	+54%	+$6.17M	0.4%	35
2023 Q4	$10.3M	Buy	66,235 +5,305	+9%	+$773K	0.36%	34
2023 Q3	$9.08M	Buy	60,930 +21,692	+55%	+$3.18M	0.41%	30
2023 Q2	$5.29M	Sell	39,238 -5,894	-13%	-$864K	0.3%	48
2023 Q1	$7.19M	Buy	45,132 +3,491	+8%	+$534K	0.48%	24
2022 Q4	$6.73M	Buy	41,641 +15,636	+60%	+$2.4M	0.5%	26
2022 Q3	$3.49M	Buy	26,005 +4,375	+20%	+$628K	0.45%	28
2022 Q2	$3.31M	Buy	21,630 +4,369	+25%	+$668K	0.48%	26
2022 Q1	$2.8M	Buy	17,261 +3,958	+30%	+$575K	0.43%	34
2021 Q4	$1.8M	Buy	+13,303	New	+$1.57M	0.33%	63
2019 Q3	–	Sell	-9,568	Closed	-$696K	–	371
2019 Q2	$696K	Buy	+9,568	New	+$752K	0.41%	38
2019 Q1	–	Sell	-4,335	Closed	-$400K	–	363
2018 Q4	$400K	Buy	+4,335	New	+$381K	0.33%	110

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quantinno Capital Management's ABBV Position: Q2 2026 in Review

Quantinno Capital Management increased its AbbVie (ABBV) stake by 20% in Q2 2026, buying an estimated $40.2M and bringing the position to 1,138,736 shares worth $287M. The position accounts for 0.34% of the portfolio, ranked #30.

Quantinno Capital Management first reported a position in ABBV in Q4 2018 and has held it in 21 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Quantinno Capital Management held 1,138,736 shares of AbbVie worth $287M as of Q2 2026.
Quantinno Capital Management bought 186,646 AbbVie shares in Q2 2026, an estimated $40.2M.
AbbVie made up 0.34% of Quantinno Capital Management's portfolio in Q2 2026, its #30 holding.
Quantinno Capital Management first reported a position in AbbVie in Q4 2018 and has held it in 21 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.